Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 833, pseudogene (RNU6-833P) is classified as a **pseudogene** of the U6 small nuclear RNA (snRNA) gene family[1]. U6 snRNA is the crucial RNA component of U6 small nuclear ribonucleoprotein, which forms a key part of the spliceosome complex and is essential for catalyzing the removal of introns from pre-mRNA in eukaryotes[5][3]. However, **RNU6-833P itself is a pseudogene**, meaning it is a non-functional genetic element that does not encode an active snRNA molecule. Such pseudogenes are commonly found in the human genome as processed or unprocessed copies of essential RNA genes and typically lack biological activity, although in rare cases, certain pseudogenes have been shown to contribute to disease processes or regulation by acting as decoys for microRNAs or modulating gene expression in a competitive endogenous RNA network[2]. For RNU6-833P in particular, there is no direct evidence of biological function or disease association[1]. This gene does not represent a therapeutic target, nor does it have established roles in canonical cellular processes or as a pharmacological biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 833, pseudogene (RNU6-833P).